A new model using artificial intelligence to predict recurrence after surgical resection of stage I-II non-small cell lung cancer.
Natalie Lui, Nien Wei, Winston Trope, Shannon Nesbit, Prasha Bhandari, Chin-Hui Lee, Hu Hu, H. Henry Guo, Douglas Z. Liou, Joseph B. Shrager, Leah Monique Backhus, Mark F. Berry, Eric Yang Stanford University, Stanford, CA; Auspex Diagnostics, Warren, NJ; Georgia Institute of Technology, Atlanta, GA DOI: 10.1200/JCO.2021.39.15_suppl.8537 Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021) 8537-8537.
Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection
Yu-Chung Wu, Nien-Chih Wei, Jung-Jyh Hung, Yi-Chen Yeh, Li-Jen Su, Wen-Hu Hsu1, and Teh-Ying Chou;
Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
Department of Surgery, School of Medicine, National Yang-Ming University, Taipei, Taiwan
Auspex Diagnostics, Taipei, Taiwan
Division of Molecular Pathology, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan
Core Facilities for High Throughput Experimental Analysis, Institute of Systems Biology and Bioinformatics, National Central University, Jhong-Li, Taiwan
Oncotarget. 2017; 8:79712-79721
Building personalized treatment plans for early-stage colorectal cancer patients
Jeng-Kai Jiang, Hung-Shin Lin, Jen-Kou Lin, Yu-Chung Wu, Teh-Ying Chou, Nien Wei; Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Auspex Diagnostics, Taipei, Taiwan
DOI: 10.18632/oncotarget.14638
The development of complete personalized treatment plans for colon cancer patients utilizing three gene prediction models.
Jeng-Kai Jiang, Hung-Shin Lin, Jen-Kou Lin, Yu-Chung Wu, Teh-Ying Chou, Nien Wei; Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan; Auspex Diagnostics, Taipei, Taiwan
2014 ASCO Annual Meeting
Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms
Chang JW1, Wei NC, Su HJ, Huang JL, Chen TC, Wu YC, Yu CT, Hou MM, Hsieh CH, Hsieh JJ, Wu CE, Cheng HY, Hsu T, Wang TH. Division of Hematoloy-Oncology, Genomic Medicine Research Core Lab, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC. Anticancer Research April 2012 vol. 32 no. 4 1259-1265
Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling
Zachariah E. Selvanayagam, Tak Hong Cheung, Nien Wei, Ragini Vittal, Keith Wing Kit Lo, Winnie Yeo, Tsunekazu Kita, Roald Ravatn, Tony Kwok Hung Chung, Yick Fu Wong, Khew-Voon Chin
Cancer Genetics and Cytogenetics, Volume 154, Issue 1, Pages 63-66 (1 October 2004)